Jacqueline Elizabeth Shea Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Jacqueline Elizabeth Shea is Chief Executive Officer of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 33,647 shares of INO, which is worth approximately $300,467. The most recent transaction as insider was on May 15, 2024, when has been sold 7,718 shares (Common Stock) at a price of $13.07 per share, resulting in proceeds of $100,874. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.6K

64.04% 3M change

83.02% 12M change

Total Value Held $300,467

Jacqueline Elizabeth Shea Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	SELL Payment of exercise price or tax liability	$100,874 $13.07 p/Share	7,718 Reduced 18.66%	33,647 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	17,745 Added 30.02%	41,365 Common Stock
May 10 2024	SELL Payment of exercise price or tax liability	$25,474 $10.65 p/Share	2,392 Reduced 9.2%	23,620 Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	-	5,500 Added 17.45%	26,012 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$30,420 $8.16 p/Share	3,728 Reduced 15.38%	20,512 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	7,731 Added 24.86%	23,368 Common Stock
May 10 2023	SELL Payment of exercise price or tax liability	$23,250 $0.81 p/Share	28,704 Reduced 12.66%	198,113 Common Stock

May 10 2023	BUY Exercise of conversion of derivative security	-	66,000 Added 22.54%	226,817 Common Stock
Mar 11 2023	SELL Payment of exercise price or tax liability	$29,357 $1.13 p/Share	25,980 Reduced 13.91%	160,817 Common Stock
Mar 11 2023	BUY Exercise of conversion of derivative security	-	59,737 Added 24.23%	186,797 Common Stock
Feb 26 2023	SELL Payment of exercise price or tax liability	$54,109 $1.28 p/Share	42,273 Reduced 24.96%	127,060 Common Stock
Feb 26 2023	BUY Exercise of conversion of derivative security	-	92,778 Added 36.77%	159,545 Common Stock
Mar 25 2022	SELL Payment of exercise price or tax liability	$26,307 $3.63 p/Share	7,247 Reduced 8.65%	76,555 Common Stock
Mar 25 2022	BUY Exercise of conversion of derivative security	-	16,666 Added 16.59%	83,802 Common Stock
Mar 11 2022	SELL Payment of exercise price or tax liability	$83,636 $3.22 p/Share	25,974 Reduced 27.9%	67,136 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	-	59,737 Added 39.08%	93,110 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$34,660 $3.22 p/Share	10,764 Reduced 24.39%	33,373 Common Stock
Feb 26 2022	BUY Exercise of conversion of derivative security	-	22,545 Added 33.81%	44,137 Common Stock
Jun 09 2021	SELL Open market or private sale	$385,735 $10.01 p/Share	38,535 Reduced 64.09%	21,592 Common Stock
Mar 26 2021	SELL Open market or private sale	$42,249 $8.97 p/Share	4,710 Reduced 7.26%	60,127 Common Stock
Mar 25 2021	SELL Payment of exercise price or tax liability	$65,658 $9.06 p/Share	7,247 Reduced 10.05%	64,837 Common Stock
Mar 25 2021	BUY Exercise of conversion of derivative security	-	16,667 Added 18.78%	72,084 Common Stock
Mar 12 2021	SELL Open market or private sale	$169,823 $10.06 p/Share	16,881 Reduced 23.35%	55,417 Common Stock
Mar 11 2021	SELL Payment of exercise price or tax liability	$274,545 $10.57 p/Share	25,974 Reduced 26.43%	72,298 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	-	59,737 Added 37.81%	98,272 Common Stock

JES

Jacqueline Elizabeth Shea

Chief Executive Officer

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account